Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 213815
Company: APPCO

Products on ANDA 213815

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 213815

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/26/2020	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 213815

RAMELTEON

TABLET;ORAL; 8MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	091610	ACTAVIS LABS FL INC
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	215435	ANDAS 5 HOLDING
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	213815	APPCO
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	215972	AUROBINDO PHARMA LTD
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	091693	DR REDDYS LABS SA
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	212650	I3 PHARMS
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	215243	MICRO LABS
RAMELTEON	RAMELTEON	8MG	TABLET;ORAL	Prescription	No	AB	211567	ZYDUS PHARMS
ROZEREM	RAMELTEON	8MG	TABLET;ORAL	Prescription	Yes	AB	021782	TAKEDA PHARMS USA